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Prospective Isolation And Characterization Of Mononucleated And Binucleated 
Cardiomyocytes 
Abstract 
Loss of cardiomyocytes through cardiac injury and disease substantially impairs cardiac function. Given 
that cardiomyocytes permanently exit the cell cycle soon after birth, the heart has traditionally been 
considered a terminally differentiated organ, and thus unable to effectively regenerate. However, recent 
discoveries have challenged this paradigm and have provided the foundation for exploring the prospect of 
inducing cardiomyocytes to reenter the cell cycle and, in turn, regenerate damaged myocardium. This has 
proven challenging, as mammalian cardiomyocytes appear to lose competency to respond robustly to 
pro-proliferative stimuli following a neonatal maturation period. During this maturation period, 
cardiomyocytes exit the cell cycle, undergo structural and metabolic changes, and most become 
binucleated. We and others have observed that the small percentage of mature cardiomyocytes that 
remain mononucleated (MoNuc) are more competent to respond to proliferative stimuli than their 
binucleated (BiNuc) counterparts and therefore offer a biological model with which to interrogate loss of 
proliferative competency in cardiomyocytes. We hypothesized that differences in the maturation 
processes of MoNucs and BiNucs leave them differentially primed to respond to proliferative stimuli. We 
devised a novel method to obtain populations highly enriched in MoNuc and BiNuc cardiomyocytes by 
fluorescence associated cell sorting (FACS) and profiled the transcriptional differences between MoNuc 
and BiNuc cardiomyocytes at three different timepoints spanning cardiomyocyte maturation. 
Transcriptome analysis revealed that during the neonatal period, binucleation is associated with the 
termination of a proliferation-associated gene expression program in exchange for a mature 
cardiomyocyte gene expression program. Our data also suggested that an E2f/Rb transcriptional network 
is central to the divergence of these two populations and that remnants of the differences acquired during 
the neonatal period remain in adult cardiomyocytes. Furthermore, we induced binucleation by genetically 
blocking the ability of cardiomyocytes to complete cytokinesis, which allowed us to directly link 
binucleation to changes in Rb/E2f signaling and loss of regenerative competency. The research presented 
in this dissertation suggests a potential mechanism by which the binucleation process may result in loss 
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PROSPECTIVE ISOLATION AND CHARACTERIZATION OF 
MONONUCLEATED AND BINUCLEATED CARDIOMYOCYTES 
Rebecca Windmueller 
Edward E. Morrisey 
Loss of cardiomyocytes through cardiac injury and disease substantially impairs cardiac 
function. Given that cardiomyocytes permanently exit the cell cycle soon after birth, the 
heart has traditionally been considered a terminally differentiated organ, and thus unable 
to effectively regenerate. However, recent discoveries have challenged this paradigm and 
have provided the foundation for exploring the prospect of inducing cardiomyocytes to 
reenter the cell cycle and, in turn, regenerate damaged myocardium. This has proven 
challenging, as mammalian cardiomyocytes appear to lose competency to respond 
robustly to pro-proliferative stimuli following a neonatal maturation period.  During this 
maturation period, cardiomyocytes exit the cell cycle, undergo structural and metabolic 
changes, and most become binucleated. We and others have observed that the small 
percentage of mature cardiomyocytes that remain mononucleated (MoNuc) are more 
competent to respond to proliferative stimuli than their binucleated (BiNuc) counterparts 
and therefore offer a biological model with which to interrogate loss of proliferative 
competency in cardiomyocytes. We hypothesized that differences in the maturation 
processes of MoNucs and BiNucs leave them differentially primed to respond to 
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proliferative stimuli. We devised a novel method to obtain populations highly enriched 
in MoNuc and BiNuc cardiomyocytes by fluorescence associated cell sorting (FACS) 
and profiled the transcriptional differences between MoNuc and BiNuc cardiomyocytes 
at three different timepoints spanning cardiomyocyte maturation. Transcriptome analysis 
revealed that during the neonatal period, binucleation is associated with the termination 
of a proliferation-associated gene expression program in exchange for a mature 
cardiomyocyte gene expression program. Our data also suggested that an E2f/Rb 
transcriptional network is central to the divergence of these two populations and that 
remnants of the differences acquired during the neonatal period remain in adult 
cardiomyocytes. Furthermore, we induced binucleation by genetically blocking the 
ability of cardiomyocytes to complete cytokinesis, which allowed us to directly link 
binucleation to changes in Rb/E2f signaling and loss of regenerative competency. The 
research presented in this dissertation suggests a potential mechanism by which the 
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CHAPTER 1: BACKGROUND AND APPROACH 
 
1.1 INTRODUCTION 
Acute myocardial infarction can result in the loss of upwards of one billion 
cardiomyocytes (Murry et al., 2006). The adult mammalian heart is unable to effectively 
replace these lost cardiac muscle cells, and instead, undergoes a maladaptive remodeling 
process that includes hypertrophy and fibrotic scar formation. These events severely 
impair the ability of the heart to generate force and can often progress to heart failure 
(Braunwald and Bonow, 2012). Given its response to injury, the heart has traditionally 
been considered a terminally differentiated organ, incapable of regeneration (Porrello and 
Olson, 2014).  However, as our understanding of cardiac biology has grown more 
complex, this dogma has been increasingly challenged. The result has been the 
emergence of the field of cardiac regeneration—the search for a means to replace 
cardiomyocytes lost through injury.   
 
1.2 APPROACHES TO CARDIAC REGENERATION 
Several different schools of thought have materialized on how cardiac 
regeneration may be facilitated. The research approaches taken can be generally 
categorized by the potential source of replacement cardiomyocytes they investigate.   
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Endogenous stem cells 
Considerable effort has gone into determining whether a population of stem or 
progenitor cells exists in the heart, analogous to the population of satellite cells 
responsible for regenerating skeletal muscle (Beauchamp et al., 1999; Mauro, 1961). 
Initial reports suggested a stem cell population, which could be identified by cell surface 
expression of receptor tyrosine kinase c-kit, exists in the adult mammalian heart and is 
capable of differentiating into new cardiomyocytes (Beltrami et al., 2003). While this 
area of research has been clouded by controversy, a consensus now holds that these cells 
do not represent a potential source for cardiomyocyte renewal (Eschenhagen et al., 2017; 
Ozkan, 2019).  
 
Exogenous stem cells 
Another active area of research focuses on transplanting exogenously sourced 
cardiac myocytes that have been differentiated from embryonic stem cells (ES cells) or 
induced pluripotent stem cells (iPS cells) (Kehat et al., 2001; Mauritz et al., 2008). While 
this approach is compelling, several significant roadblocks have come to light. Despite 
efforts to optimize differentiation and maturation strategies, a significant challenge 
remains that ES- and iPS-derived myocytes do not fully recapitulate mature myocytes. 
Stem cell-derived cardiomyocytes resemble immature embryonic cardiomyocytes both 
structurally and functionally and have reduced capacity for force generation, excitation-
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contraction coupling, and energy production (Yang et al., 2014).  However, it is not clear 
whether the maturation state of transplanted cells affects their ability to integrate into a 
recipient heart successfully. Upon transplantation into non-human primates, ES-derived 
myocytes do appear to partially integrate into the myocardium but caused arrhythmias in 
all treated animals (Chong et al., 2014). Therefore, the potential held by these cells to 
contribute to cardiac regeneration remains to be determined.   
 
Reprogramming of mature cells 
The discovery that differentiated cells, such as fibroblasts, could be 
reprogrammed into pluripotent cells through the expression of a set of transcription 
factors, led to studies that examined whether fibroblasts could also be reprogrammed 
directly into cardiomyocytes (Takahashi and Yamanaka, 2006). This strategy is intriguing 
because it would utilize the cells responsible for fibrotic scar formation as a source of 
new cardiomyocytes. A combination of four factors known to play critical roles in 
cardiogenesis, Gata4, Mef2c, Tbx5, and Hand2, were subsequently identified to be able 
to induce mouse cardiac fibroblasts to take on characteristics of cardiomyocytes (Ieda et 
al., 2010; Qian et al., 2012). However, significant challenges that must be overcome 
include low reprogramming efficiency and immature maturation state of induced 




Proliferation of endogenous cardiomyocytes 
During embryonic development, proliferation of cardiomyocytes contributes to 
the growth of the heart, but soon after birth, cardiomyocytes of the mammalian heart exit 
the cell cycle and switch to a hypertrophic mechanism of growth (Li et al., 1996; Oparil 
et al., 1984).  A final approach to cardiac regeneration is based on the premise of 
developing therapies that reactivate the proliferation of endogenous cardiomyocytes to 
regenerate damaged tissue. This approach sets the foundation for the research presented 
in this dissertation. 
 
1.3 PROLIFERATION AND REGENERATION IN THE HEART  
Accumulating evidence has shown that in certain contexts, the heart is capable of 
regeneration through the proliferation of endogenous cardiomyocytes. A number of lower 
vertebrate and amphibian species, including zebrafish and newt, can fully regenerate 
myocardium after experimental injuries as severe as apical resection (Oberpriller and 
Oberpriller, 1974; Poss et al., 2002). Subsequent experiments utilized cardiomyocyte-
specific cmlc2a-Cre-Ert2 lineage tracing in the zebrafish heart to show that the formation 
of new myocardium can be attributed to the proliferation of pre-existing cardiomyocytes 
(Kikuchi et al., 2010; Jopling et al., 2010). During regeneration, cardiomyocytes were 
observed to break down their sarcomere structure and express genes involved in the cell 
cycle but did not appear to undergo extensive dedifferentiation. 
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Furthermore, the mammalian heart displays a robust regenerative capacity during 
embryonic development (Drenckhahn et al., 2008; Sturzu et al., 2015). The murine heart 
retains this ability through the early postnatal period (Porrello et al., 2011). In response to 
apical resection of the heart at postnatal day 1, a-MHC-MerCreMer lineage traced 
cardiomyocytes entered the cell cycle and were observed to disassemble the sarcomere 
structure, mirroring the regenerative response observed in the zebrafish. However, 
cardiomyocytes were not able to mount a regenerative response when the injury occurred 
at postnatal day 7. This loss of regenerative response is concurrent with cardiomyocyte 
cell cycle exit during the first week after birth.  The neonatal mouse heart responds 
similarly to an experimental injury model of myocardial infarction (Haubner et al., 2012). 
 
Finally, several intriguing studies have been published noting the capacity of the 
neonatal human heart to fully recover after infarction. In one case study, a newborn 
presented with thrombotic occlusion of the left anterior descending artery within hours of 
birth (Haubner et al., 2016). High serum levels of troponin T signified the death of 
cardiomyocytes, and the child continued to show severe impairment of cardiac function 
in the days immediately following thrombolysis and re-establishment of coronary blood 
flow. However, by six weeks later, the child had regained complete cardiac function and 
showed no signs of injury. In fact, children as old as twelve have shown complete 
recovery of cardiac function after myocardial infarction (Celermajer et al., 1991).  
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While the regenerative ability of the heart appears to be lost over both 
evolutionary and developmental time, the possibility of reactivating the regenerative 
potential of the mammalian heart is supported by studies that show that a low level of 
cardiomyocyte turnover does occur during the lifetime of both the mouse and human 
(Mollova et al., 2013; Senyo et al., 2013). One study took advantage of a spike in 
atmospheric levels of carbon-14 (14C) during nuclear bomb tests during the cold war to 
age cardiomyocytes from deceased individuals (Bergmann et al., 2009). The investigators 
isolated cardiac troponin-positive cardiomyocytes by FACS, extracted DNA, and 
assessed levels of 14C in individuals born before and after the increase in 14C. They then 
developed a mathematical model that suggested that new cardiomyocyte turnover does 
occur, albeit at a low rate, over the human lifetime. Taken together, these observations 
suggest that by understanding and modulating the mechanisms responsible for 
cardiomyocyte proliferation and regeneration, we could potentially accelerate the 
proliferation of cardiomyocytes for the regeneration of damaged tissue.  
 
1.4 CARDIOMYOCYTE CELL CYCLE STUDIES 
A large body of research has explored the possibility of experimentally 
manipulating the proliferative dynamics of cardiomyocytes. These studies have largely 
focused on modulating cell cycle regulators or growth factor pathways (Agah et al., 1997; 
Engel et al., 2005; Liao et al., 2001; MacLellan et al., 2005; Poolman et al., 1999; 
Soonpaa et al., 1997; Xiao et al., 2001). Several more recent studies have focused on the 
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Hippo pathway (Heallen et al., 2013; Leach et al., 2017; Tian et al., 2015; Xin et al., 
2013). A number of groups have reported increased cardiomyocyte proliferation, but the 
responses largely do not appear to be robust enough for meaningful regeneration after 
injury. However, these studies have revealed valuable insights into cardiomyocyte 
proliferation that have guided ongoing research in the field, including the work presented 
in this dissertation. 
 
Cardiomyocytes face multiple barriers to cell cycle progression   
Several early studies used transgenic models to modulate the expression of 
individual cell cycle regulators and observed that in response, cardiomyocytes underwent 
additional partial rounds of the cell cycle (Liao et al., 2001; Poolman et al., 1999).  
Overexpression of cyclin D1 or c-Myc each resulted in DNA synthesis and increased 
polyploidy and multinucleation in cardiomyocytes of the adult heart (Soonpaa et al., 
1997; Xiao et al., 2001). Overexpression of cyclin D1 also resulted in increased 
cardiomyocytes size (hypertrophy).  These observed phenotypes can result from 
premature cell cycle exit (Figure 1.1) and suggest that cardiomyocytes underwent 
additional rounds of DNA synthesis in response to stimuli but faced additional obstacles 
that impeded completion of the cell cycle. Therefore, it appears that cardiomyocytes 
experience barriers to division at multiple different stages of the cell cycle. These 
observations also raise significant challenges in assessing cardiomyocyte proliferation. 
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Standard measures of cell proliferation, including measurements of BrdU incorporation 
and stains for phosphorylated Histone H3 and Aurora B kinase, do not definitively mark 
proliferating cardiomyocytes but instead only reveal how far into the cell cycle a 
cardiomyocyte has progressed at a given time. This has remained a significant challenge 
in the field. While no available technique conclusively shows cardiomyocyte 
proliferation, the most rigorous assessments use a combination of BrdU incorporation 
assays, cell cycle marker stains,  and either quantification of increased cardiomyocyte 
number in the heart or time-lapse imaging of dividing cardiomyocytes (Figure 1.2).  
 
Proliferation and differentiation are linked 
Later studies identified experimental strategies that led to more robust activation 
of the cardiomyocyte cell cycle and, in doing so, also revealed new challenges. Hearts 
deficient in pocket proteins Rb and p130 showed strong upregulation of several key cell 
cycle regulators and contained cardiomyocytes positive for BrdU and phosphorylated 
histone H3. However, these changes were accompanied by the expression of the 
immature isoform of the myosin heavy chain (MHC) gene and decreased cardiac function 
(MacLellan et al., 2005). Work from our lab showed that transgenic overexpression of the 
microRNA family miR-302/367 activates the cardiomyocyte cell cycle at least in part 
through repression of the Hippo pathway (Tian et al., 2015). However, prolonged 
reactivation of the cell cycle also led to the expression of genes associated with immature 
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cardiomyocytes and a disorganized sarcomere structure. These indications of 
dedifferentiation were accompanied by decreased cardiac function. In contrast, transient 
delivery of miR-302/367 mimics resulted in improved cardiac function after injury. In 
addition to the challenges they raise, these results also suggest that regulation of 
proliferation and maturation of cardiomyocytes are closely linked.  
 
 Cardiomyocytes appear to lose competency to respond to proliferative stimuli 
Studies have shown that the cardiomyocyte cell cycle can be reactivated in 
response to several different experimental strategies. However, reported measurements of 
DNA synthesis by BrdU incorporation suggest that an extremely limited proportion of 
adult cardiomyocytes undergo even early stages of the cell cycle in response to these 
stimuli (Figure 1.3).  In several studies, however, early neonatal cardiomyocytes were 
shown to respond more robustly to stimuli.  Treatment of postnatal day 2 rat 
cardiomyocytes with a combination of FGF1 and a p38 MAP kinase inhibitor resulted in 
BrdU incorporation in approximately 80% of treated cardiomyocytes compared to 5% of 
untreated cardiomyocytes. In contrast, when adult cardiomyocytes were treated with the 
same conditions, approximately 4% of cells incorporated BrdU (Engel et al., 2005). 
Similar trends resulted from stimulation with growth factor neuregulin1 or transgenic 
overexpression of receptor tyrosine kinase ErbB4 (Bersell et al., 2009). These 
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observations suggest that events occur during the neonatal period that act to shut off the 
ability of cardiomyocytes to respond to proliferative stimuli.  
 
Mononucleated cardiomyocytes retain increased proliferative competency 
 Two studies reported that a higher proportion of mononucleated cardiomyocytes 
(MoNucs) than binucleated cardiomyocytes (BiNucs) reactivate the cell cycle in response 
to proliferative stimuli (Bersell et al., 2009; Kuhn et al., 2007) (Figure 1.3). Our lab also 
observed this trend as a result of adenoviral-mediated delivery of the miR-302/367 
transcript to adult rat cardiomyocytes in vitro. While MoNucs comprise a small fraction 
of adult rat cardiomyocytes, they were highly overrepresented in the cardiomyocytes that 
responded to miR-302/367 (Figure 1.4). These data suggest that though mature 
cardiomyocytes largely appear to lack competency to respond to proliferative stimuli, 
MoNucs may represent a subset of cardiomyocytes with increased proliferative 
competency. Moreover, these observations suggest that mononucleated and binucleated 
cardiomyocytes could provide a biological model with which to interrogate loss of 
proliferative competency.  
 
 The insights gained from these studies begin to piece together a picture of the 
rules and roadblocks that govern cardiomyocyte proliferation. They also bring to light 
many intriguing new questions. The research presented in this dissertation aims to 
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address some of these questions: 1) What events are responsible for the loss of 
proliferative competency during the postnatal maturation period? 2) What are the 
molecular differences underlying the distinct proliferative responses of MoNucs and 
BiNucs? 3) Do differences in the maturation processes undergone by MoNucs and 
BiNucs leave them differentially competent to respond to proliferative stimuli?  
 
 The remainder of this chapter will discuss our current understanding of the 
relationship between binucleation, the postnatal maturation period, and the loss of 
proliferative competency. 
 
1.5 BINUCLEATION OF CARDIOMYOCYTES 
During embryonic development, almost all cardiomyocytes are mononucleated, 
which correlates with ongoing cardiomyocyte proliferation to drive organ growth. Soon 
after birth, cardiomyocytes of the mammalian heart undergo a transition period associated 
with cell cycle exit and maturation. During cell cycle exit, karyokinesis (nuclear division) 
and cytokinesis (cytoplasmic division) become uncoupled in the murine heart. 
Cardiomyocytes undergo a final round of DNA synthesis and nuclear division but do not 
complete cytokinesis (Li et al., 1996). These events occur between postnatal days 4 and 7 
and result in a high percentage of binucleated cardiomyocytes (Soonpaa et al., 1996). 
After this period, only a small minority of cardiomyocyte remain mononucleated. 
Between postnatal days 2 and 4, cardiomyocytes appear to lose their ability to fully 
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disassemble myofibrils during cell division and this has been proposed to be responsible 
for failed cytokinesis and subsequent binucleation (Li et al., 1996). However, a different 
study reported successful myofibril disassembly and instead suggested that failed 
cytokinesis is the result of the mis-localization of the cytokinesis protein anillin (Engel et 
al., 2006).  The study suggested that improper localization of anillin results in the 
disfunction of the actomyosin contractile ring responsible for carrying out cytokinesis. 
Therefore, the events responsible for the binucleation of cardiomyocytes remain 
incompletely resolved.  
 
In recent years,  new reports have provided further evidence that MoNucs retain 
an increased potential to proliferate and to contribute to cardiac regeneration. Patterson et 
al. characterized 120 different inbred mouse strains and found that the percentage of 
diploid MoNucs in the heart varied from approximately 2% to 10%.  The investigators 
took advantage of this natural variation to show a positive correlation between the 
percentage of MoNucs in the heart and the number of cells that re-enter the cell cycle 
after injury as well as functional repair of the heart after injury (Patterson et al., 2017). 
Another intriguing study used the zebrafish as a model, which retains a lifelong capacity 
for cardiac regeneration and contains almost solely MoNucs under physiological 
conditions. The authors of this study expressed a dominant-negative Ect2 in zebrafish 
cardiomyocytes to induce polyploidy and binucleation and showed that it impaired the 
heart’s ability to regenerate after injury (Gonzalez-Rosa et al., 2018). Despite these 
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intriguing observations, there have been no studies directly comparing MoNucs and 
BiNucs in the mammalian heart, and the molecular basis for their distinct proliferative 
responses remains unclear. 
 
1.6 REGULATION OF CELL CYCLE EXIT 
Cell cycle exit and maturation during the neonatal period are accompanied by 
large scale, programmatic shifts in the gene expression profile of cardiomyocytes. Over 
late embryonic development and through the postnatal period, a multitude of genes 
involved in the cell cycle are downregulated, while those associated with cardiomyocyte-
specific processes are upregulated (Uosaki et al., 2015). The onset of cell cycle exit and 
maturation can be altered to various degrees in response to experimental manipulation of 
many different pathways that include Hippo, Rb/E2f, FGF, Myc, and Cdks/Cyclins 
(Engel et al., 2005; MacLellan et al., 2005; Poolman et al., 1999; Tian et al., 2015; Xiao 
et al., 2001; Xin et al., 2011). Therefore, it has remained a significant challenge to 
determine the relative contributions of these different pathways to cell cycle exit, 
binucleation, and loss of proliferative competency.   
 
Cell cycle exit and maturation are tightly coupled to birth and have been proposed 
to occur at least in part as a response to exposure to oxygen. The switch from a hypoxic 
environment to an oxygen-rich environment results in reactive oxygen species 
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production, which in turn activates a DNA damage response pathway (Puente et al., 
2014). It is this pathway that is thought to potentially initiate cell cycle exit and 
mitochondrial biogenesis. In contrast, there is also evidence that pathways related to the 
cell cycle and maturation begin to change expression levels during late embryonic 
development (Uosaki et al., 2015). Therefore, the upstream events that initiate cell cycle 
exit and maturation of cardiomyocytes remain incompletely resolved.  
 
1.7 CARDIOMYOCYTE MATURATION 
During the neonatal period, cell cycle exit and binucleation of cardiomyocytes are 
accompanied by structural and metabolic changes that leave the heart better prepared to 
meet the high physical and metabolic demands placed on it over the mammalian lifetime. 
These changes may also not be conducive to cell division.   
 
The sarcomere is the contractile unit of the cardiomyocyte and is composed of 
actin and myosin along with a large number of proteins involved in scaffolding and 
mechanotransduction. Repeating sarcomere units comprise myofibrils, which must break 
down, at least in part, for cell division to occur (Ahuja et al., 2004). During neonatal 
cardiomyocyte maturation, the sarcomere structure becomes more highly organized and 
rigid, which allows it to generate more force (Jacot et al., 2010; Murphy, 1996; Siedner et 
al., 2003). Changes in sarcomere organization and density are reflections of the 
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upregulation and expression of alternate isoforms of sarcomere components (Lahmers et 
al., 2004; Saggin et al., 1989). While myofibrils were observed to disassemble during cell 
division in 2-day-old rat cardiomyocytes, they do not do so completely in cardiomyocytes 
from 4-day-old rats (Li et al., 1996; Li et al., 1997). During cardiac regeneration in 
zebrafish,  proliferating cardiomyocytes transiently break down myofibrils (Jopling et al., 
2010). Therefore, the inability of the sarcomere structure to break down in mammalian 
cardiomyocytes is thought to be a potential barrier to the completion of cytokinesis in 
cardiomyocytes and to contribute to the formation of BiNucs during the postnatal period.  
 
During embryonic development, cardiomyocytes utilize glycolytic metabolism for 
energy. Within days after birth, there is a dramatic decrease in glycolysis as 
cardiomyocytes switch to instead utilize fatty acid b-oxidation as the primary energy 
source (Lopaschuk and Jaswal, 2010). This switch is accompanied by a marked increase 
in mitochondrial mass and ultrastructural rearrangements that ensure myofibrils are 
continuously able to receive a high supply of ATP (Piquereau et al., 2010). Interestingly, 
rapidly proliferating cells, including cancer cells, have been found to rely primarily on 
glycolytic metabolism (Warburg, 1925). It has been proposed that a proliferating cell may 
require glycolysis because glycolytic intermediates provide the raw material for the 
biosynthesis of nucleic acids, proteins, and lipids necessary to make a new cell (Lunt and 
Vander Heiden, 2011).  It is currently unknown whether a limited capacity for glycolytic 
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metabolism in mature cardiomyocytes plays any role in restricting their ability to re-enter 
the cell cycle.   
 
1.8 MAINTENANCE OF THE TERMINALLY DIFFERENTIATED STATE 
Widespread epigenetic changes occur during cardiomyocyte maturation and are 
thought to maintain the mature state of cardiomyocytes after the neonatal period. DNA 
methylation increases globally in cardiomyocytes over the neonatal period (Kou et al., 
2010). Furthermore, ATAC-seq has shown that promoters of genes associated with the 
cell cycle become less accessible over cardiomyocyte maturation, while those associated 
with sarcomere structure and metabolism become more accessible (Quaife-Ryan et al., 
2017). Genes that regulate DNA synthesis have been shown to acquire H3K9me3 and 
H3K27me3 histone modifications and CpG methylation changes over cardiomyocyte 
maturation (Gilsbach et al., 2018; Kou et al., 2010). While these changes are known to 
occur over maturation, their role in inhibiting cardiomyocyte proliferation and 
regeneration remains an area of active research. 
 
1.9 HYPOTHESIS AND APPROACH 
The research presented in this dissertation aims to further our understanding of the 
mechanisms responsible for the loss of proliferative competency of cardiomyocytes.  We 
sought to gain insight into how the cell cycle is permanently shut off to better understand 
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how we might turn it back on. We have employed mononucleated and binucleated 
cardiomyocytes as a biological model of differential proliferative competency. The two 
cardiomyocyte subsets diverge during a neonatal period associated with cell cycle exit, 
maturation, and loss of regenerative capacity. We hypothesized that differences in the 
maturation processes undergone by mononucleated and binucleated cardiomyocytes leave 
them differentially primed to respond to proliferative stimuli. To address this hypothesis, 























Figure 1.1 The Cardiomyocyte Cell Cycle 
Cardiomyocytes can progress partially through the cell cycle and exit prematurely. Cells 
that exit the cell cycle during G1 may be hypertrophic. Cells that undergo DNA synthesis 
but do not complete mitosis become polyploid. Cells also may begin mitosis but exit the 
cell cycle between karyokinesis and cytokinesis. This results in multinucleated cells. 
Cardiomyocytes can exist in hypertrophic, polyploid, and multinucleated states under 
physiological conditions but also as a result of pathological conditions or in response to 





















Figure 1.2 Reports of cell cycle progression in response to proliferative stimuli  
Cardiomyocytes can partially progress through the cell cycle before prematurely exiting. 
Therefore, the data shown here does not show true cardiomyocyte proliferation but 
instead how far in the cell cycle the cardiomyocyte has been able to progress at a given 
time. The furthest point in the cell cycle reported for different pro-proliferative stimuli 
are shown. (Bersell et al., 2009; Engel et al., 2005; Heallen et al., 2013; Kuhn et al., 
2007; Lavine et al., 2005; Liao et al., 2001; Pasumarthi et al., 2005; Soonpaa et al., 1996; 

















Figure 1.3 Reports of DNA synthesis in response to proliferative stimuli  
Reported measures of BrdU incorporation in adult cardiomyocytes in response to 
proliferative stimuli are shown in pink. Typical percentages of cycling cardiomyocytes in 
the embryonic heart reported in the literature are shown in purple for comparison. Data 
shows that the majority of cardiomyocytes fail to undergo even early stages of the cell 
cycle in response to proliferative stimuli. Two studies report that a higher percentage of 
mononucleated cardiomyocytes than binucleated cardiomyocytes reactivate the cell 
cycle. (Bersell et al., 2009; Engel et al., 2005; Heallen et al., 2013; Kuhn et al., 2007; 
Lavine et al., 2005; Liao et al., 2001; Pasumarthi et al., 2005; Soonpaa et al., 1996; von 

























Figure 1.4 MoNucs are overrepresented in cardiomyocytes that respond to miR-
302/367  
Measures of cell cycle activation by immunostaining 6d after in vitro adenoviral 
mediated infection of the miR-302/367 transcript in freshly isolated rat cardiomyocytes.  
Percentages are reported as cell staining positive for the specified cell cycle reporter out 
of total cells staining positive for cardiomyocyte marker Sarcomeric a-actinin. Taking 
into account that only ~10% of adult murine cardiomyocytes are mononucleated, this 






CHAPTER 2: DIRECT COMPARISON OF MONONUCLEATED AND 
BINUCLEATED CARDIOMYOCYTES REVEALS MOLECULAR 
MECHANISMS UNDERLYING DISTINCT PROLIFERATIVE 
COMPETENCIES 
 
2.1 SUMMARY  
Several reports have demonstrated that mononucleated (MoNuc) cardiomyocytes 
are more responsive to pro-proliferative stimuli than are binucleated (BiNuc) 
cardiomyocytes. However, techniques to isolate and characterize these two different 
cardiomyocyte populations have been lacking. To address whether the developmental 
divergence of MoNucs and BiNucs contributes to their differential response to 
proliferative stimuli, we developed a novel strategy to separate MoNuc and BiNuc 
cardiomyocytes using fluorescence-activated cell sorting (FACS). We assessed the 
transcriptional differences between these subsets of cardiomyocytes across late 
development and in the adult. These data revealed that during the neonatal period, 
binucleation is associated with the silencing of genes that permit the onset of DNA 
synthesis, specifically those that are targets of the E2f transcription factor family, and the 
upregulation of a set of genes involved in cardiomyocyte maturation. Remnants of the 
differences between MoNucs and BiNucs established during the neonatal period remain 
at the adult stage. Furthermore, we showed that Rb is required for the down-regulation of 
E2f target genes that we observed to occur. 
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2.2 MONONUCLEATED AND BINUCLEATED CARDIOMYOCYTES CAN BE 
SEPARATED BY FACS 
We sought to characterize transcriptional differences between MoNuc and BiNuc 
cardiomyocytes during maturation from late embryonic development through adulthood. 
Single-cell suspensions were prepared from hearts at the indicated timepoints to be sorted 
by FACS (Figure 2.1A). A wide nozzle was used to accommodate the large size of 
mature cardiomyocytes. A wide nozzle also subjects the cardiomyocytes to lower shear 
stress than is typical for FACS (Shapiro, 1985). Ventricular cardiomyocytes were lineage 
labeled with Mlc2vcre:R26REYFP, and nuclei were stained with VybrantTM DyeCycleTM 
DNA dye. The intensity of the fluorescent signal emitted by this dye is proportional to the 
DNA quantity. The dye is used to assess DNA content and ploidy of nuclei by FACS 
(Patterson et al., 2017). Cells were gated on EYFP presence then determined to be 
MoNucs or BiNucs by a strategy that combines the use of DyeCycleTM dye with the 
concept behind doublet discrimination (Figure 2.1B). Doublet discrimination is used in 
FACS analysis to exclude instances where two cells are stuck together and are therefore 
characterized as a single event. Doublet discrimination takes into account the width 
(time), and the height (voltage intensity) of the signal produced and assumes that two 
cells will produce a signal of greater width than a single cell, while the height of the 
signal will remain the same. We utilized a similar metric to distinguish BiNucs from 
MoNucs. Nucleation was gated on the height and width of the fluorescent signal 
produced by 405nm laser excitation of DyeCycleTM dye. (Figure 2.2A-C).  The nuclei of 
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BiNucs produced a signal of equal intensity to that produced by diploid MoNucs but of 
greater width. MoNucs with increased voltage intensity, presumed to be polyploid or 
undergoing DNA synthesis, were excluded. Since the size and shape of cardiomyocytes 
change over maturation, each timepoint required tailored gating parameters. These 
parameters were empirically fine-tuned to maximize enrichment by sorting cells onto 
microscope slides for visualization of nucleation (Figure 2.2D-I). The relative 
percentages of MoNucs and BiNucs collected at each timepoint faithfully reflects the 
developmental switch to BiNucs being the predominant cardiomyocyte subtype, and 
agree with reported percentages of MoNucs and BiNucs over cardiomyocyte maturation 
(Ikenishi et al., 2012). This methodology resulted in greater than 70% enrichment of 
either MoNucs or BiNucs at the E18.5 timepoint and greater than 90% enrichment at the 
P7 and adult timepoints (Figure 2.2J-L). We quantified the viability of sorted 
cardiomyocytes by propidium iodide (PI) staining. At each timepoint, >97% of cells 
remained negative for PI after being sorted (Figure 2.3A-B). Finally, we expanded the 
application of our FACS strategy to separate adult MoNucs and BiNucs without the 
requirement of a lineage marker (Figure 2.4A). We reasoned that a long rod-shaped 
cardiomyocyte would produce a wider light scatter than a smaller round non-myocyte, 
similar to our gating for two nuclei versus one. To quantify the ability of this strategy to 
identify cardiomyocytes accurately, we gated lineage traced cells on the width of side 
scatter and then backgated on YFP fluorescence, showing that 99.1% of cells identified 
are cardiomyocytes by their YFP expression (Figure 2.4B-C). Importantly, we were able 
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to separate MoNucs and BiNucs by their distinct light scatter with equal success rates 
using this strategy (Figure 2.4D-E). Together, the techniques described here allowed us to 
isolate highly enriched populations of lineage labeled MoNuc and BiNuc cardiomyocytes 
from E18.5, P7, and adult mice to assess changes in gene expression during 
cardiomyocyte maturation. 
 
2.3 BINUCLEATION IS ACCOMPANIED BY A SWITCH FROM A 
PROLIFERATION- TO MATURATION-ASSOCIATED GENE EXPRESSION 
PROGRAM 
To characterize transcriptional differences between MoNucs and BiNucs over the 
neonatal maturation period, we sorted MoNuc and BiNuc cardiomyocyte populations and 
performed RNA-seq analysis.  The Principal Component Analysis (PCA) shows that at 
each timepoint, MoNucs and BiNucs are transcriptionally distinct with the primary and 
secondary components accounting for 76.2% and 9.6% respectively of the variance 
across all of the samples (Figure 2.5A). At E18.5, BiNucs were enriched for genes 
involved in cell division, including several genes known to be involved in cytokinesis 
(Figure 2.6). This data suggests that at this timepoint, cardiomyocytes identified as 
BiNucs may have still been undergoing or attempting to undergo cytokinesis. The RNA-
seq data revealed that MoNucs and BiNucs exhibit the most statistically significant 
differences in gene expression at P7. To further characterize the set of genes differentially 
expressed between P7 MoNucs and BiNucs, we examined their expression levels across 
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all samples. (Figure 2.7A). We observed that the expression of this set of genes also 
changes significantly between the embryonic and adult timepoints. The genes 
upregulated in P7 MoNucs tend to be more highly expressed in both embryonic 
cardiomyocyte populations compared to adult cardiomyocytes, whereas the genes 
upregulated in P7 BiNucs tend to be enriched in both adult cardiomyocyte populations 
versus embryonic cardiomyocytes. Gene set enrichment analysis (GSEA) showed that P7 
MoNucs are enriched for genes involved in the cell cycle, especially those that are E2f 
targets and those involved in DNA synthesis (Figure 2.7B, Figure 2.8A-B, Table 2.1). In 
contrast, P7 BiNucs are enriched for genes involved in cardiomyocyte maturation 
processes, including sarcomere organization and a switch to fatty acid oxidative 
metabolism (Figure 2.7B, Figure 2.8C-D, Table 2.2). Together, this data indicates that 
during the postnatal period, cardiomyocyte binucleation is accompanied by the 
termination of the fetal gene expression program, including genes required for 
proliferation, in exchange for activation of the mature cardiomyocyte gene expression 
program. 
 
2.4 BINUCLEATED CARDIOMYOCYTES AT P7 TURN OFF E2F TARGET GENE 
EXPRESSION REQUIRED FOR G1/S PHASE TRANSITION  
Transcriptome analysis revealed that at P7, binucleation is accompanied by the 
termination of a gene expression program closely associated with regulating the onset of 
proliferation. To gain insight into which transcription factors may be involved in 
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regulating the apparent switch in transcription program, we analyzed the promoters of 
differentially expressed genes at P7 for the enrichment of DNA binding sites and 
associated transcription factors. This analysis revealed that binucleation is accompanied 
by down-regulation of targets of the E2f transcription factor family, whereas genes 
upregulated in P7 BiNucs are targets of the Ppara, Esrra, Mef2, and Myod transcription 
factors (Figure 2.9A). The E2f transcription factor family is known to control the onset of 
DNA synthesis (Nevins, 1992). Our RNA-seq data shows that 54% of the top 50 down-
regulated genes in P7 BiNucs are targets of E2f that are known to regulate the G1/S 
transition and onset of DNA synthesis (Figure 2.9B, C).  This down-regulation occurs 
most dramatically between P7 MoNucs and BiNucs (Figure 2.10A). In addition to their 
target genes, four of the E2f family members, E2f1, E2f2, E2f7, and E2f8, were strongly 
down-regulated in P7 BiNucs (Figure 2.10B). These data demonstrate that DNA 
synthesis and onset of the cell cycle is dramatically down-regulated in association with 
binucleation in P7 cardiomyocytes, through silencing of E2f target genes.  
 
2.5 ADULT MONONUCLEATED AND BINUCLEATED CARDIOMYOCYTES 
RETAIN DIFFERENCES ESTABLISHED DURING NEONATAL MATURATION 
To determine whether differences between P7 MoNucs and BiNucs remained in 
adult cardiomyocytes, we compared the transcriptional profiles of MoNucs and BiNucs 
from adult hearts.  Transcriptionally, these cardiomyocyte subsets are quite similar, with 
only three differentially expressed genes with an FDR  < 0.05 (Figure 2.11A). However, 
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two of these genes, Necdin and Cenpf, are known to be involved in the regulation of 
E2f/Rb signaling (Papadimou et al., 2005; Taniura et al., 1998).  456 genes had a non-
adjusted p-value < 0.05 (Figure 2.11B). GSEA of these genes revealed enrichment of 
categories related to those that are differentially expressed between P7 MoNucs and 
BiNucs (Figure 2.11C, Table 2.3). While adult MoNucs are enriched for genes involved 
in DNA synthesis and G2 phase of the cell cycle, adult BiNucs are enriched for genes 
involved in fatty acid oxidation. Furthermore, several of the most highly downregulated 
E2f target genes in the P7 BiNucs remain downregulated in the Adult BiNucs (Figure 
2.11D). Together, this data shows that adult MoNucs and BiNucs retain remnants of 
transcriptional differences established during the neonatal maturation period.  
 
To further examine differences between adult MoNucs and BiNucs, we performed 
transmission electron microscopy studies on sorted cardiomyocytes. We observed that 
adult BiNucs have a significantly higher density and buildup of glycogen granules 
surrounding the mitochondria than do MoNucs (Figure 2.12A-B). Glycogen granules are 
a stored energy source that is depleted when used to drive glycolytic metabolism (Prats et 
al., 2018; Schneider et al., 2014). This observation suggests that metabolic differences 
exist between adult MoNucs and BiNucs. One possible explanation for this observation is 
that diploid adult MoNucs may utilize glycolytic metabolism more readily than BiNucs 
and are therefore not able to maintain stores of excess glycogen. This would be consistent 
with the switch away from glycolytic metabolism that occurs during cardiomyocyte 
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maturation and the oxidative metabolism gene expression profile that we observed to be 
enriched in BiNucs at the P7 and adult stages. These data further support the concept that 
adult MoNucs and BiNucs retain remnants of differences established during the neonatal 
maturation period.  
 
2.6  RB IS REQUIRED FOR DOWNREGULATION OF E2F TARGET GENES  
E2f activity is known to be regulated by Rb, and this interaction can have 
temporary, as well as long term control over entry into S phase of the cell cycle 
(Harrington et al., 1998; Lundberg and Weinberg, 1998; Nevins, 1992).  Previous work 
has shown that Rb family members are required for cell cycle exit of cardiomyocytes 
during the postnatal period (MacLellan et al., 2005). Furthermore, Rb recruits HP1-g to 
H3K9me3 marks at a subset of E2f target genes to stably repress their expression during 
cardiomyocyte maturation (Sdek et al., 2011). Therefore, we sought to determine whether 
Rb is required for the repression of E2f target genes that we saw to be depleted in P7 
BiNucs. We utilized a triple Rb family knockout mouse model, 
Rbflox/flox;p130flox/flox;p107-/- (Viatour et al., 2008) to determine the role of the Rb family 
in cardiomyocyte binucleation. Cardiomyocytes were isolated from P1 mice and infected 
with either adenoviral-Cre/GFP (TKO) or adenoviral-GFP (control) in vitro (Figure 
2.13A). QPCR revealed strong downregulation of the Rb1 transcript in TKO 
cardiomyocytes (Figure 2.13B). We then quantified the percentage of GFP+ MoNucs and 
BiNucs in both control and TKO samples to determine whether Rb activity regulates the 
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onset of binucleation. There was no difference in the ratio of BiNucs to MoNucs between 
control and TKO cardiomyocytes (Figure 2.13C-D). QPCR revealed that TKO 
cardiomyocytes strongly upregulated E2f target genes whose expression are decreased in 
P7 BiNucs versus MoNucs (Figure 2.13E). In contrast, non-E2f targets were upregulated 
to a lesser degree in TKO cardiomyocytes (Figure 2.13E-F). Together this data suggests 
that Rb is required for down-regulation of E2f target genes in neonatal cardiomyocytes 























Figure 2.1 Schematic of MoNuc and BiNuc sorting strategy 
 (A) Schematic of experimental design to collect mononucleated (MoNucs) and 
binucleated (BiNucs) cardiomyocytes for RNA-sequencing analysis. Single-cell 
suspensions are isolated from the hearts of Mlc2vcre:R26REYFP mice at age E18.5, P7, and 
adult. Nuclei are stained with VybrantTM DyeCycleTM  DNA dye. Cardiomyocytes are 
identified by FACS as YFP+ and then sorted by nucleation. (B) Schematic of sorting 
strategy for separating MoNucs and BiNucs. As nuclei of cardiomyocytes pass the 405 
nm laser, DyeCycleTM DNA dye is activated and produces a signal of which the width is 
proportional to the length of time the nuclei travel through the laser. Two nuclei (BiNucs) 
take longer to travel past the laser than one nucleus (MoNucs) and produce two 
overlapping signals, which are interpreted as a single signal of greater width. The height 
of the signal produced is proportional to DNA content per nucleus, allowing the separate 
gating of diploid and polyploid cells. MoNucs and BiNucs, cluster separately on a plot of 

















Figure 2.2 Results of FACS sorting to separate MoNucs and BiNucs 
(A-C) Representative flow cytometry plots of the width versus height of the 405 channel. 
Gates used to sort E18.5 (A), P7 (B), and adult (C) MoNucs and BiNucs are shown. 
Mean percentages of total YFP+ cells that fall inside MoNuc or BiNuc gates are 
indicated. n=3 animals for each timepoint. (D-I) Cropped images of live 
Mlc2vcre:R26REYFP MoNucs (D, F, H,) and BiNucs (E, G, I) sorted onto slides according 
to gates shown in (A-C). Scale bar, 50 μm. (J-L) Percentages of cells correctly and 
incorrectly sorted into indicated groups as determined by slide images taken during sorts. 









Figure 2.3 Validation and Viability of FACS methods  
(A) Viability testing of FACS sorted cardiomyocytes. Cropped images of live E18.5, P7, 
adult Mlc2vcre:R26REYFP MoNucs and BiNucs stained with Propidium Iodide. 
Cardiomyocytes gated on negative Propidium iodide staining were sorted onto slides 
according to gates shown in (Figure 2.1 A-C) and imaged to determine levels of cell 
death associated with the sorting process. Scale bar, 200 μm. (B) Quantification of 
percentages of cells staining positive and negative for Propidium iodide after FACS 

















Figure 2.4 Expanded FACS strategy allows the sorting of cardiomyocytes without a 
lineage marker 
(A) Adult CD-1 MoNuc and BiNuc cardiomyocytes sorted onto slides with expanded 
FACS strategy. Scale bar, 50 μm (B) FACS plots showing expanded FACS strategy. (C) 
The success of the expanded FACS strategy tested on Mlc2vcre:R26REYFP 
cardiomyocytes. Histogram showing >99% of cells gated as cardiomyocytes are YFP+. 
(D) Testing relative ability of expanded FACS strategy to identify MoNucs and BiNucs 
as cardiomyocytes. FACS plot showing further gating of the cardiomyocytes identified in 
(B) to separate MoNucs and BiNucs. (E) Histograms showing lineage tracing of 
identified MoNucs and BiNucs. >99% of both MoNucs and BiNucs identified as 












Figure 2.5 MoNucs and BiNucs are transcriptionally distinct at all analyzed 
timepoints  
(A) Principal component analysis (PCA) from RNA-seq of MoNucs and BiNucs from 
E18.5, P7, and adult hearts shows that at each timepoint, MoNucs and BiNucs are 
transcriptionally distinct. n=3 animals per timepoint  
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 Figure 2.6  RNA seq analysis of E18.5 MoNucs versus BiNucs 





Figure 2.6  RNA seq analysis of E18.5 MoNucs versus BiNucs                                     
(A) Heatmap of top 50 differentially expressed genes in E18.5 MoNucs versus BiNucs.  
(B) Representative categories from gene set enrichment analysis (GSEA) of differential 
gene expression between E18.5 MoNucs and BiNucs. Analysis was done using Camera. 
Results suggest that at E18.5, cardiomyocytes collected as BiNucs are likely still in the 













Figure 2.7 At P7, binucleation is accompanied by a switch from a proliferation-







Figure 2.7 At P7, binucleation is accompanied by a switch from a proliferation-
associated gene expression program to one associated with maturation 
(A) Heatmaps of genes with significant differences (FDR < 0.05) in expression between 
P7 MoNucs and BiNucs. Gene expression values are represented at P7 only (top) and at 
all timepoints (bottom). The bottom heatmap reveals that the gene expression profile of 
P7 BiNucs but not P7 MoNucs shows resemblance to profiles of adult samples. The 
difference in intensity between the top and bottom heatmaps is due to the different scales 
used. (B) Representative categories from gene set enrichment analysis (GSEA) of 
differential gene expression between P7 MoNucs and BiNucs. P7 MoNucs are enriched 
for genes involved in the cell cycle, while P7 BiNucs are enriched for genes involved in 















Figure 2.8 Heatmaps of genes included in GSEA categories                                            
(A-D) Heatmaps of gene sets included in Figure 2.7. E2f target gene heatmap shows the 
















Figure 2.9 Binucleated cardiomyocytes at P7 turn off E2f target gene expression 




Figure 2.9 Binucleated cardiomyocytes at P7 turn off E2f target gene expression 
required for G1/S phase transition and S phase  
(A) Enriched transcription factor motifs within promoters of genes differentially 
expressed between P7 MoNucs and BiNucs reveals E2f target genes are most highly 
enriched. Analysis was performed using the Toppgene suite. (B) Analysis of the top 50 
differentially expressed genes between P7 MoNucs and BiNucs reveals 66% (33/50) are 
involved in G1/S transition and S phase of the cell cycle, 27 of which (54%, 27/50) are 
E2f target genes. (C) Gene set enrichment analysis plot of E2f target genes differentially 



















Figure 2.10 E2f target gene expression decreases specifically between P7 MoNucs 
and BiNucs 
Expression values of (A) E2f target genes and (B) indicated E2f family members and are 
shown across all samples. Significance of differences in gene expression between E18.5 
and P7 MoNucs and between P7 MoNucs and BiNucs are indicated. Data are mean ± 
SEM. n=3 animals per timepoint. p-values are determined by student’s t-test. ns=not 












Figure 2.11 Adult mononucleated and binucleated cardiomyocytes retain differences 






Figure 2.11 Adult mononucleated and binucleated cardiomyocytes retain differences 
established during neonatal maturation  
(A) Expression values measured by RNA-seq of genes with FDR < 0.05 between adult 
MoNucs and BiNucs. Data are mean ± SEM. n=3 animals 
per timepoint. (B) Heatmap of gene expression differences with p-value < 0.05 between 
Adult MoNucs and BiNucs. (C) Representative categories from gene set enrichment 
analysis (GSEA) of differential gene expression between Adult MoNucs and BiNucs 
reveals overlap with categories enriched between P7 MoNucs and BiNucs. Analysis was 
done using Camera. (D) A subset of E2f target genes most differentially expressed 
between P7 MoNucs and BiNucs remain differentially expressed between Adult MoNucs 
and BiNucs. The expression values of these genes are shown in P7 and Adult samples. 
Significance of differences in gene expression between P7 MoNucs and BiNucs and 
between Adult MoNucs and BiNucs are indicated. Data are mean ± SEM. n=3 animals 
per timepoint. p-values are determined by student’s t-test. ns=not significant, *=p<0.05, 
**=p<0.01, ***=p<0.001, ****=p<0.0001.  
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Figure 2.12 Adult BiNucs have a higher density of glycogen granules        
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Figure 2.12 Adult BiNucs have a higher density of glycogen granules.                      
(A) Electron micrographs of sorted adult MoNucs and BiNucs. Scale bar, 1 μm. (B) 
Quantification of glycogen granule density in non-sarcomeric cytoplasmic space 
visualized by electron microscopy. Significance of difference between adult MoNucs and 
BiNucs is indicated Data are mean ± SEM. n=5 cells per sample. p-values are determined 














Figure 2.13 Rb acts downstream of binucleation and is required for downregulation 






Figure 2.13 Rb acts downstream of binucleation and is required for downregulation 
of E2f target genes 
(A) Schematic of experimental design of in vitro Rb family knockout experiments. 
Cardiomyocytes were isolated from Rbflox/flox;p130flox/flox;p107-/- mice at P1 and infected 
with adenovirus containing either Cre and GFP (Ad-Cre/GFP) or GFP alone (Ad-GFP). 
Cells infected with Ad-Cre/GFP are denoted as Triple Knockout (TKO) samples, and 
cells infected with Ad-GFP are denoted as Control samples. (B) Expression values of the 
Rb transcript in TKO samples compared to control samples by qPCR. Data are mean ± 
SEM. n=5 animals. (C) Confocal images of fixed TKO MoNuc and BiNuc 
cardiomyocytes stained with antibodies against α-actinin and GFP. Scale bar, 20 μm. (D) 
Quantification of the ratio of BiNucs to MoNucs and percentages of MoNucs and BiNucs 
in GFP+ control and TKO cardiomyocytes fixed and stained with antibodies against α-
actinin and GFP. n=3 animals. Data are mean ± SEM. p-values are determined by 
student’s t-test (E) Gene expression differences between Control and TKO samples of 
E2f target genes and non-E2f target genes by qPCR. Data are mean ± SEM. n=5 animals. 
p-values are determined by student's t-test. (F) Comparison of mean fold change 
expression of TKO samples over control samples of E2f target genes versus non-E2f 
target genes. p-values are determined by student's t-test. ns=not significant, *=p<0.05, 




Table 2.1 Top 10 upregulated Gene Ontology and Hallmark categories at P7 
(Enriched in MoNucs at P7)  
GO Category Direction PValue FDR 
GO:0006261 DNA-dependent DNA replication Up 2.18E-27 3.27E-23 
GO:0005657 replication fork Up 4.05E-26 3.03E-22 
GO:0006270 DNA replication initiation Up 6.45E-26 3.22E-22 
GO:0006260 DNA replication Up 2.02E-23 7.56E-20 
GO:0042555 MCM complex Up 3.99E-17 1.19E-13 
GO:0030894 replisome Up 2.48E-15 6.20E-12 
GO:0007059 chromosome segregation Up 4.44E-15 9.50E-12 
GO:0000793 condensed chromosome Up 7.72E-15 1.45E-11 
GO:0043596 nuclear replication fork Up 4.88E-14 8.13E-11 
GO:0000775 chromosome, centromeric region Up 6.55E-14 9.82E-11 
Hallmark Category Direction PValue FDR 
HALLMARK_E2f_targets Up 1.44E-48 7.19E-47 
HALLMARK_G2M_checkpoint Up 8.14E-18 2.03E-16 
HALLMARK_epithelial_mesenchymal_transition Up 2.18565E-05 0.000182137 
HALLMARK_DNA_repair Up 0.001340747 0.009576765 
HALLMARK_cholesterol_homeostasis Up 0.004767588 0.026879478 
HALLMARK_estrogen_response_late Up 0.004838306 0.026879478 
HALLMARK_Myc_targets_V1 Up 0.007929791 0.039648953 
HALLMARK_mitotic_spindle Up 0.013387727 0.060853302 
HALLMARK_UV_response_up Up 0.041094641 0.139505466 






Table 2.2 Top 10 downregulated Gene Ontology and Hallmark categories at P7 
(Enriched in BiNucs at P7)  
GO Category Direction PValue FDR 
GO:0044455 mitochondrial membrane part Down 4.17E-11 3.47E-08 
GO:0006099 tricarboxylic acid cycle Down 5.58E-11 4.40E-08 
GO:0070469 respiratory chain Down 6.97E-11 5.22E-08 
GO:0005746 mitochondrial respiratory chain Down 4.76E-10 2.55E-07 
GO:0045333 cellular respiration Down 1.40E-09 5.39E-07 
GO:0005743 mitochondrial inner membrane Down 1.88E-09 6.71E-07 
GO:0006635 fatty acid beta-oxidation Down 6.45E-09 2.10029E-06 
GO:0005747 mitochondrial respiratory chain complex I Down 1.93E-08 5.35634E-06 
GO:0030964 NADH dehydrogenase complex Down 1.93E-08 5.35634E-06 
GO:0045271 respiratory chain complex I Down 1.93E-08 5.35634E-06 
Hallmark Category Direction PValue FDR 
HALLMARK_oxidative_phosphorylation Down 2.67E-16 4.44E-15 
HALLMARK_adipogenesis Down 8.34E-07 1.04207E-05 
HALLMARK_fatty_acid_metabolism Down 6.47395E-06 6.47395E-05 
HALLMARK_bile_acid_metabolism Down 0.014783457 0.061597739 
HALLMARK_protein_secretion Down 0.030395013 0.116903895 
HALLMARK_peroxisome Down 0.04207603 0.139505466 
HALLMARK_heme_metabolism Down 0.044641749 0.139505466 
HALLMARK_myogenesis Down 0.100500333 0.228409848 
HALLMARK_notch_signaling Down 0.227691276 0.44370498 





Table 2.3 All differentially expressed Gene Ontology and Hallmark categories in 
Adult MoNucs versus BiNucs  
GO Category Direction PValue FDR 
GO:0000085 G2 phase of mitotic cell cycle Up 9.08E-08 0.000680188 
GO:0051319 G2 phase Up 9.08E-08 0.000680188 
GO:0072329 monocarboxylic acid catabolic process Down 3.98E-07 0.001050164 
GO:0009062 fatty acid catabolic process Down 4.54E-07 0.001050164 
GO:0019395 fatty acid oxidation Down 5.87E-07 0.001050164 
GO:0034440 lipid oxidation Down 5.87E-07 0.001050164 
GO:0018879 biphenyl metabolic process Up 6.31E-07 0.001050164 
GO:0018917 fluorene metabolic process Up 6.31E-07 0.001050164 
GO:0018585 fluorene oxygenase activity Up 6.31E-07 0.001050164 
GO:0006635 fatty acid beta-oxidation Down 1.50631E-06 0.002256606 
GO:0070402 NADPH binding Down 1.22356E-05 0.015973572 
GO:0030258 lipid modification Down 1.27951E-05 0.015973572 
GO:0006733 oxidoreduction coenzyme metabolic 
process Down 3.13271E-05 0.036100915 
GO:0003995 acyl-CoA dehydrogenase activity Down 4.24762E-05 0.045452598 
HALLMARK Category Direction PValue FDR 
HALLMARK_fatty_acid_ metabolism Down 2.16142E-05 0.001080708 
HALLMARK_adipogenesis Down 0.000156879 0.003921965 
HALLMARK_epithelial_mesenchymal_transition Up 0.002099963 0.028172254 
HALLMARK_oxidative_ phosphorylation Down 0.00225378 0.028172254 
HALLMARK_bile_acid_ metabolism Down 0.00377872 0.037787197 
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CHAPTER 3: BINUCLEATION LEADS TO SILENCING OF E2F 
TRANSCRIPTION FACTOR ACTIVITY AND IMPAIRS REGENERATIVE 
CAPACITY DURING THE NEONATAL PERIOD 
 
3.1 SUMMARY  
The data presented in Chapter 2 showed that down-regulation of E2f target genes, 
a process that requires Rb, occurs in BiNucs at P7 but is not responsible for inducing 
binucleation. In Chapter 3, we examine whether these transcriptional changes instead 
occur as a result of binucleation.  We utilized a genetic mouse model to alter the ratio of 
BiNucs to MoNucs during the neonatal maturation period to establish a direct link 
between binucleation and E2f signaling. We also used this genetic model to examine the 
relationship between binucleation and loss of regenerative ability in the heart.  
 
3.2 INTRODUCTION 
During cytokinesis, the contractile ring is formed beneath the plasma membrane 
around the equator of the mitotic cell (Tucker, 1971).  It is built by regulatory proteins at 
the initiation of cytokinesis, and its constriction carries the plasma membrane with it 
towards the cell's center, thus dividing the cell in half. Over a range of cell types and 
organisms, the RhoA GTPase pathway is responsible for orchestrating the formation and 
contraction of the contractile ring during cytokinesis (Kamijo et al., 2006). Ect2 is the 
guanine nucleotide exchange factor (GEF) responsible for activating RhoA and is 
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required for successful cytokinesis (Fields and Justilien, 2010; Tatsumoto et al., 1999) 
(Figure 3.1). We hypothesized that loss of Ect2 in cardiomyocytes would result in failed 
cytokinesis and, therefore, an increase in the proportion of binucleated cardiomyocytes in 
the heart during the neonatal period. This model would allow us to draw direct links 
between binucleation and its downstream effects. 
 
3.3 LOSS OF ECT2 IN EMBRYONIC CARDIOMYOCYTES RESULTS IN 
INCREASED CARDIOMYOCYTE BINUCLEATION AND IS LETHAL   
We generated an Ect2flox/flox allele and first crossed it with the cardiomyocyte-
specific Nkx2.5cre allele.  Nkx2.5cre:Ect2flox/flox mice did not survive beyond E10.5 (Figure 
3.2A, C, D). At E10.5 Nkx2.5cre:Ect2flox/flox mice had altered myocardial morphology and 
a significant decrease in ventricular Ect2 expression (Figure 3.2B-D). E10.5 
Nkx2.5cre:Ect2flox/flox mutant hearts were primarily comprised of BiNucs, while control 
hearts were comprised almost exclusively of MoNucs. The mean ratio of BiNucs to 






3.4 BINUCLEATION RESULTS IN SILENCING OF E2F TRANSCRIPTIONAL 
TARGETS 
Next, we crossed our Ect2flox/flox allele with the Mlc2vcre allele. Mlc2vcre shows 
cardiomyocyte-specific expression in a mosaic fashion (Gillers et al., 2015; Guimaraes-
Camboa et al., 2015). We harvested knockout and control hearts at an early and late 
neonatal timepoint. At P7, there was no difference in Ect2 expression levels between 
Mlc2vcre:R26REYFP and control hearts (Figure 3.3A-B). This is likely because Ect2 
expression decreases over the neonatal period, so baseline Ect2 levels would be too low 
to observe a difference between the control and knockout animals. Similarly, there was 
no difference in the ratio of BiNucs to MoNucs or in the relative expression of E2f target 
genes between Mlc2vcre:R26REYFP and control mice at P7 (Figure 3.3C-D). In 
Mlc2vcre:R26REYFP hearts, we saw an increase in the proportion of cells expressing YFP 
between E18.5 and P2 by FACS, suggesting that cre-mediated recombination increases 
during the early neonatal period (Figure 3.4). Therefore, we next examined 
Mlc2vcre:Ect2flox/flox mutants at P3, at which time they exhibited a 61.8% decrease in Ect2 
expression compared to controls (Figure 3.5A-B). Mlc2vcre:Ect2flox/flox mutants had an 
increase in the mean ratio of BiNucs to MoNucs at P3 of 0.901 ± 0.08 compared to 0.339 
± 0.02 in control mice (Figure 3.5C-D). QPCR revealed a significant decrease in 
expression of E2f target genes in Mlc2vcre:Ect2flox/flox mutants compared to controls but 
no significant change in genes that are not E2f targets (Figure 3.5E-F). These data 
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suggest that the downregulation of E2f target genes occurs as a direct result of 
binucleation in cardiomyocytes. 
 
3.5 BINUCLEATION IMPAIRS REGENERATIVE ABILITY 
To examine whether these events impair the regenerative ability of the heart, we 
performed LAD ligation to induce myocardial infarction in Mlc2vcre:Ect2flox/flox mutants 
and control mice at P1 (Figure 3.6A). At this developmental timepoint, the murine heart 
is still able to mount a substantial regenerative response to injury (Porrello et al., 2011). 
We observed that at P8, a higher percentage of myocardium remained as scar tissue in 
Mlc2vcre:Ect2flox/flox mutants compared to control mice. (Figure 3.6B-C). This data 
supports a model whereby binucleation directly results in decreased competency for 




















3.1 The critical role of Ect2 in cytokinesis 
Ect2 acts as the Guanine nucleotide exchange factor (GEF) for the RhoA GTPase. 
RacGap1 may act as the GTPase activating protein (GAP) for RhoA. RacGap and 
MKLP1 form the centralspindlin complex, which recruits Ect2 to the central spindle. The 
interaction between centralspindlin and Ect2 is required for Ect2 to be active, which 
allows for the location of Ect2 activity to be tightly regulated. Active Ect2 activates 
RhoA in a locally precise manner in the overlying cortex by exchanging GDP for GTP. 
Active RhoA is responsible for inducing actin polymerization and activating myosin to 
form the contractile ring. RhoA is also responsible for regulating the actions of several 
additional proteins that induce the contraction of the contractile ring leading to cleavage 










Figure 3.2 Loss of Ect2 in the embryonic heart results in binucleation of 







Figure 3.2 Loss of Ect2 in the embryonic heart results in binucleation of 
cardiomyocytes and is lethal 
(A) Timecourse of Ect2 knockout using Nkx2.5cre. (B) Expression values of the Ect2 
transcript in Nkx2.5cre:Ect2flox/flox (HOM) samples compared to Ect2flox/flox and Ect2flox/+ 
(WT) samples at E10.5 by qPCR. Data are mean ± SEM. n=5-6 animals per group (C-D). 
Representative tissue sections of WT and HOM hearts at E10.5 and E11.5 stained with 
H&E (C) or an antibody against cardiac Troponin T (D) reveals that the 
Nkx2.5cre:Ect2flox/flox allele is lethal by E11.5. Scale bar, 100 μm. (D) Representative 
images of a MoNuc and BiNuc present in E10.5 HOM samples. Single-cell suspensions 
were cytospun and stained with an antibody against α-actinin. Scale bar, 20 μm. (E) 
Quantification of the ratio of BiNucs to MoNucs and percentages of MoNucs and BiNucs 
in E10.5 WT and HOM samples. Data are mean ± SEM. n=3 animals per group. p-values 









Figure 3.3 By P7, no differences are observed between Mlc2vcre:Ect2flox/flox and 







Figure 3.3 By P7, no differences are observed between Mlc2vcre:Ect2flox/flox and 
control mice  
(A) Timecourse of the first set of experiments knocking out Ect2 with Mlc2vcre. (B) 
Expression values of the Ect2 transcript in Mlc2vcre:Ect2flox/flox (HOM) samples compared 
to Ect2flox/flox and Ect2flox/+ (WT) samples at P7 by qPCR. Data are mean ± SEM. n=6 
animals per group. (C) Quantification of the ratio of BiNucs to MoNucs and percentages 
of MoNucs and BiNucs in P7 WT and HOM samples. Quantification of MoNucs and 
BiNucs was done by FACS. Data are mean ± SEM. n=3 animals per group. (D) Gene 
expression differences between WT and HOM samples of E2f target genes at P7. Data 












Figure 3.4 Mlc2vcre recombination increases during the early neonatal period 
FACS plots of YFP presence in cells from Mlc2vcre:R26REYFP hearts at E18.5 and P2 
show an increase in YFP+ cells between E18.5 and P2. This suggests that Mlc2vcre 


















Figure 3.5 Mlc2vcre:Ect2flox/flox results in increased binucleation at postnatal day 3 
(A) Timecourse of the second set of Ect2 knockout experiments using Mlc2vcre. (B) 
Expression values of the Ect2 transcript in Mlc2vcre:Ect2flox/flox (HOM) samples compared 
to Ect2flox/flox and Ect2flox/+ (WT) samples at P3 by qPCR. Data are mean ± SEM. n=5-6 
animals per group. (C) Images of P3 HOM MoNuc and BiNuc cardiomyocytes from 
fixed single-cell suspensions stained with anti-α-actinin. Scale bar, 20 μm. (D) 
Quantification of the ratio of BiNucs to MoNucs and percentages of MoNucs and BiNucs 
in P3 WT and HOM samples. Data are mean ± SEM. n=3 animals per group. (E) Gene 
expression differences between WT and HOM samples of E2f target genes and non-E2f 
target genes. Data are mean ± SEM. n=5-6 animals per group. p-values are determined by 




















Figure 3.6 Binucleation impairs regenerative potential 
(A) Schematic showing study design of MI by ligation of the left anterior descending 
(LAD) artery in Mlc2vcre:Ect2flox/flox mutant and control mice at P1. (B) Masson’s 
trichrome–stained heart sections from the ligation site toward the apex 7 days after injury. 
n=6 per group (C) Quantification of the percent of left ventricular myocardium 
containing scar tissue at P8. The suture location is indicated with a purple arrow. Scar 
boundaries are indicated with black arrows. Scale bar, 500 μm. Data are mean ± SEM. 
n=6 animals per group. p-values are determined by the Mann-Whitney U test. ns=not 












CHAPTER 4: CONCLUSIONS AND FUTURE DIRECTIONS 
 
4.1 DISCUSSION 
A lack of effective therapeutic strategies to treat the acutely injured heart has led 
scientists to search for a means to replace cardiomyocytes that have been lost due to 
injury. One compelling approach would be to develop therapies that activate endogenous 
cardiomyocyte proliferation to regenerate damaged tissue. While previous work has 
suggested a correlation between cardiomyocyte nucleation and the ability to re-enter the 
cell cycle, with MoNucs being more receptive to proliferative stimuli, the molecular basis 
for this difference has remained elusive, likely due to the technical hurdles in isolating 
and independently characterizing MoNucs and BiNucs. To address this question, I 
developed a novel FACS-based strategy to isolate these two cardiomyocyte populations 
at embryonic, neonatal, and adult timepoints. This methodological advancement allowed 
us to carry out the first characterization of the molecular differences between MoNucs 
and BiNucs. It will also allow for continued future work toward better understanding the 
differences between these two cardiomyocyte subsets. Furthermore, I expanded this 
FACS based approach to sort total adult cardiomyocytes without the use of a lineage 
label. This strategy takes advantage of the large size and unique shape of cardiomyocytes 
to separate them from the other cell types in the heart based on the same principles 




The MoNuc and BiNuc cardiomyocyte subsets diverge during a neonatal period 
during which time cardiomyocytes exit the cell cycle and undergo terminal 
differentiation. I examined the transcriptional profiles of MoNucs and BiNucs at 
developmental timepoints before, during, and after this neonatal transition period. We 
chose these timepoints to gain insight into how the two cardiomyocyte populations 
diverge and how their processes of cell cycle exit and maturation may differ. Our data 
revealed that MoNucs and BiNucs are most distinct during the neonatal period, as these 
subsets begin to diverge.  At P7, binucleation was associated with the termination of a 
proliferation-associated gene expression program in exchange for a mature 
cardiomyocyte gene expression program. While this programmatic switch has long been 
associated with the neonatal period, our findings show that by P7, only BiNucs have 
begun to undergo this shift, while MoNucs remain transcriptionally immature. While our 
data show that MoNucs eventually assume a similar mature gene expression program, it 
appears to do so at a later time, and not as a result of binucleation. These findings raise 
the possibility that the mechanism that couples binucleation to the observed 
transcriptional shift also contributes to the increased loss of proliferative competency 
observed in BiNucs.  
 
E2f target genes comprise a large portion of the most dramatically down-
regulated genes in P7 BiNucs, some of which remain down-regulated in adult BiNucs. 
The E2f transcription factor family is known to regulate the expression of genes required 
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to initiate DNA synthesis (Johnson et al., 1993). While cardiomyocytes continue to 
undergo hypertrophic growth after the neonatal maturation period, the S phase is the 
earliest phase of the cell cycle they do not enter under physiological conditions. E2f 
activity is known to be regulated by Rb, and this interaction can have temporary, as well 
as long term control over entry into S phase (Harrington et al., 1998; Lundberg and 
Weinberg, 1998; Nevins, 1992). Rb mediated silencing of E2f target genes is involved in 
irreversible exit of the cell cycle during senescence, leaving cells unable to respond to 
proliferative stimuli (Narita et al., 2003). While the phosphorylation state of Rb dictates 
temporary repression of S phase entry during the cell cycle, other post-translational 
modifications to Rb regulate its ability to irreversibly terminate the cell cycle (Kwon et 
al., 2017; Markham et al., 2006; Saddic et al., 2010). Previous work has also shown that 
Rb family members are required for cell cycle exit of cardiomyocytes during the 
postnatal period (MacLellan et al., 2005). This offers an intriguing potential mechanism 
by which the binucleation process could be coupled to irreversible cell cycle exit.    
 
We knocked out Rb in vitro in neonatal cardiomyocytes to examine its role in 
binucleation and the depletion of E2f target genes we observed in P7 BiNucs. While the 
loss of Rb family members did not result in a difference in the ratio of BiNucs to 
MoNucs, it did result in increased expression of E2f target genes depleted in P7 BiNucs. 
This places Rb downstream of binucleation and shows that in neonatal cardiomyocytes, 
Rb is required for down-regulating E2f target gene expression.  
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In Chapter 3 of this dissertation, I showed that we could alter the ratio of BiNucs 
to MoNucs during both the embryonic and neonatal periods by knocking out Ect2 in the 
heart. By altering the ratio of BiNucs to MoNucs during the neonatal maturation period, 
we demonstrated that increased binucleation at P3 led to decreased expression of E2f 
target genes. This data supports the hypothesis that Rb mediated silencing of E2f target 
genes during the neonatal period is a direct result of binucleation. Recent work from 
Hirose et al. further supports the direct connection we observed between binucleation and 
E2f target gene expression. This work shows that increasing the percentage of diploid 
MoNucs by expression of a dominant negative thyroid hormone receptor-a is associated 
with the upregulation of E2f signaling and downregulation of oxidative phosphorylation 
gene expression (Hirose et al., 2019).   
 
We also used our Ect2 knockout model to show a direct connection between 
binucleation and regeneration after injury in the murine heart. Increased binucleation 
during the neonatal period was accompanied by impaired regeneration after ligation of 
the left anterior descending artery. This data suggests that the loss of regenerative 
competency is a result of the binucleation process.  
 
4.2 FUTURE DIRECTIONS 
In work detailed in this dissertation, I aimed to investigate a link between 
binucleation and loss of ability to re-enter the cell cycle. Over the last few years, several 
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new reports have shown that this connection is biologically meaningful, and it has 
quickly become an important focus in efforts to modulate the regenerative abilities of the 
heart. The work presented in this dissertation begins to fill in details of the mechanism 
that connects binucleation to loss of regenerative capacity and, in doing so, raises several 
new exciting questions and possibilities. It is my hope that the questions outlined below 
are included among those focused on in future work.     
 
As a result of binucleation, does Rb mediate epigenetic changes responsible for the loss 
of proliferative competency?  
The data presented in Chapters 2 and 3 of this dissertation point to a key role for 
the Rb/E2f pathway in mediating the link between binucleation and loss of proliferative 
competency. This possibility is supported by the known roles of the Rb/E2f  pathway in 
regulating permanent cell cycle exit. In senescent cells, regulation of irreversible cell 
cycle exit by Rb includes the recruitment of chromatin-modifying proteins that alter the 
architecture of E2f target genes (Blais et al., 2007; Frolov and Dyson, 2004).  CpG 
methylation changes and histone modifications to E2f target genes are also known to 
occur during the process of cardiomyocyte maturation (Gilsbach et al., 2018; Sdek et al., 
2011). Recent work showed that E2f transcription factor networks are among those that 
undergo extensive chromatin remodeling during the postnatal period and therefore fail to 
reactivate in adult cardiomyocytes after injury (Quaife-Ryan et al., 2017). Therefore, our 
83 
 
data, together with our current understanding of the Rb/E2f pathway, strongly suggests 
that Rb may mediate epigenetic changes as a result of binucleation. This offers an 
intriguing explanation for the results presented in this dissertation, and future work will 
be necessary to examine this possibility.   
 
What is the functional relevance of the differences we observed between adult MoNucs 
and BiNucs? 
We observed that adult MoNucs and BiNucs retain remnants of some of the 
differences established during the neonatal period, including differences in E2f target 
gene expression. Rb mediated differences in the chromatin state of E2f target genes 
would not only provide an explanation for the differences in proliferative competencies 
observed between adult MoNucs and BiNucs, but it would also offer a potential 
explanation for the modest transcriptional differences we observed in E2f target genes 
between Adult MoNucs and BiNucs. These minor differences in transcript levels of genes 
that are largely not expressed in this context may not be responsible for functional 
differences but instead be a reflection of epigenetic differences between the two cell 
types.   
 
Furthermore, we observed by electron microscopy that adult MoNucs and BiNucs 
appear to have different densities of glycogen granules. This suggests that MoNucs and 
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BiNucs may have differences in energy utilization or storage. Future work will be 
necessary to better understand whether there are indeed metabolic differences between 
adult MoNucs and BiNucs. Furthermore, if there are differences, it remains to be 
determined whether they contribute to discrepancies in proliferative competency.   
 
Is a specific set of conditions required to pair the binucleation process to loss of 
proliferative competency?  
Interestingly, induced binucleation via loss of Ect2 led to E2f target gene 
inhibition at P3 but not at E10.5. We also did not see the same degree of a transcriptional 
switch in BiNucs at E18.5 compared to BiNucs at P7. Taken together, this suggests that 
conditions present during the neonatal period, but not the embryonic period, may act to 
couple binucleation with depletion of E2f target genes. Previous research suggests that 
the increase in environmental oxygen following birth results in DNA damage by reactive 
oxygen species. These events have been proposed to initiate the cell cycle exit of 
cardiomyocytes (Puente et al., 2014). DNA damage-associated cell cycle exit has been 
observed to be mediated by methylated or acetylated Rb (Markham et al., 2006; Saddic et 
al., 2010). Perhaps these events must occur in order for binucleation to be paired to the 
transcriptional switch we observed to occur during the neonatal but not embryonic 
period. Future work would be needed to examine whether a set of upstream conditions 
are required for binucleation to result in the transcriptional shift we observed. The answer 
to this question may offer valuable insight into how these events are linked and whether 
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they could be unlinked for the purposes of increasing the proliferative competency of 
cardiomyocytes.   
How do our results apply to the human heart? 
While a majority of adult murine cardiomyocytes are binucleated, the majority of 
adult cardiomyocytes in the human heart are thought to be mononucleated and polyploid 
(Bergmann et al., 2011; Brodsky et al., 1980). Therefore, the applicability of our findings 
to the human heart remains to be determined. However, the processes resulting in 
binucleation and polyploidy share similarities, and both can result from failed cell 
division, whether at the karyokinesis stage or the cytokinesis stage.  Karyokinesis and 
cytokinesis are tightly coupled processes and are orchestrated by a shared group of 
molecular regulators (Jeyaprakash et al., 2007; McCollum, 2004). Therefore, it is 
possible that whether destined to become polyploid or binucleated, human and mouse 
cardiomyocytes share similar molecular mechanisms responsible for, and in response to, 
failure of cardiomyocytes to complete cell division. First, however, it should be 
determined whether mononucleated diploid cardiomyocytes in the human heart retain 
increased proliferative and regenerative competency compared to polyploid and 
binucleated cardiomyocytes.  Work in zebrafish shows that induced binucleation and 
polyploidy impairs cardiac regeneration, and we showed that this holds true in the mouse 
heart as well. This would suggest that the link between binucleation or polyploidy and 
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loss of proliferative competency is conserved over evolution, but future experiments will 
be necessary to confirm whether this is the case.  
4.3 CONCLUDING REMARKS 
In this dissertation, I described a novel method to separate mononucleated and 
binucleated cardiomyocytes, which allowed for the first characterization of the 
differences between these two cell types. The data presented here provide evidence of a 
direct link between the binucleation process and the termination of a transcriptional 
program associated with proliferation. Furthermore, this analysis suggests that an E2f/Rb 
transcriptional network is centrally involved in the divergence of mononucleated and 
binucleated cardiomyocytes. This work suggests a potential mechanism by which 
binucleation may result in loss of regenerative capacity and provides a tool that will allow 
for further investigations to build on these findings. 
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CHAPTER 5: METHODS AND MATERIALS 
5.1 EXPERIMENTAL MODEL AND SUBJECT DETAILS 
Mice  
R26REYFP (Jackson Labs; cat# 006148) (Srinivas et al., 2001), ROSA26FLPe (Jackson 
Labs; cat# 009086) (Farley et al., 2000), Nkx2.5cre (Jackson Labs; cat# 024637) (Stanley 
et al., 2002), and Mlc2vcre (Jackson Labs; cat# 029465) (Chen et al., 1998) mice were 
purchased from Jackson Labs and have been previously described. To generate the 
Ect2flox/flox allele, cryopreserved sperm from the Ect2tm1a(EUCOMM)Wtsi mouse line was 
purchased from the Institut Clinique de la Souris (Illkirch, France). The mouse line was 
derived through in-vitro fertilization by the Transgenic and Chimeric Mouse Facility at 
the University of Pennsylvania. The resulting mouse was then bred with the ROSA26FLPe 
allele to remove the neomycin cassette and generate a conditional allele with LoxP sites 
flanking exon 13 (Figure 5.1). For cardiomyocyte sorting experiments, Adult (8-13 
weeks), P7, or E18.5 Mlc2vcre/+:R26REYFP/+ offspring were generated by breeding female 
R26REYFP/EYFP mice with  Mlc2vcre/+ males. For Ect2 experiments, Ect2flox/flox mice were 
bred to either Mlc2vcre/+ or  Nkx2.5cre/cre to generate mice heterozygous for both alleles. 
Resulting mice were then bred with Ect2flox/+ mice to generate litters used in experiments. 
A mix of male and female age-matched and litter-matched healthy mice were used for all 
experiments. No animals were used for more than one experiment. Animals were housed 
in breeding pairs or with sex-matched littermates in the small animal vivarium at the 
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Smilow Center for Translational Research at the Perelman School of Medicine and 
maintained in a 12-h light, 12-h dark cycle with unlimited access to food and water. DNA 
isolation for genotyping was performed by digesting tails in 50 μL Tris-EDTA, pH8 for 5 
minutes at 95°C followed by the addition of 47 μL Tris-EDTA with 3 μL of a 10 mg/ml 
stock of Proteinase K. The mixture was then incubated for 3 hours at 55°C followed by 5 
minutes at 95°C. Genotyping was performed using the primers in Table 5.1.  All animal 
procedures were approved by the University of Pennsylvania Institutional Animal Care 
and Use Committee under protocol #806345. 
5.2 LABORATORY METHODS 
Isolation of Mouse Cardiomyocytes 
Isolation of Adult Cardiomyocytes 
Cardiomyocytes were isolated from mice aged 8-13 weeks using a protocol modified 
from methods previously described (Judd et al., 2016; Robison et al., 2016; Tian et al., 
2015). Buffers were prepared on the day of isolation as follows. Cell Isolation Buffer 
(CIB): 130 mM NaCl (Sigma; S6191), 1 mM Lactic acid (Sigma; L1750), 5.4 mM KCl 
(Sigma; P3911), 25 mM HEPES (Bioworld; 0820000-3), 0.50 mM MgCl2 (Sigma; 
M9272), 0.33 mM NaH2PO4 (Sigma; S9638), 22 mM Glucose (Sigma; 16301), 20 mM 
Creatine Monohydrate (GNC; 350526), brought to pH 7.4 with 10M NaOH. 10X CIB 
stock excluding Glucose, Creatine, and NaOH was previously prepared and frozen in 
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aliquots; Digestion buffer: CIB with 60 U/mL Collagenase Type II (Worthington; 
LS004176) and 0.025 mg/mL Protease Type XIV (Sigma; P5147); Dissociation Buffer: 
CIB with 1 mg/mL BSA (Omnipor; 2960). Mice were injected with 100 USP units 
Heparin (Abraxis; 401586B) 25 minutes prior to removal of the heart.  Mice were 
terminally anesthetized with Isoflurane, and the heart was removed and placed in ice-cold 
CIB. The heart was cannulated via the aorta, secured with 5-0 silk suture, and mounted 
on a Langendorf apparatus. The heart was then perfused with CIB for 3 min at a 
temperature of 37°C and a constant flow rate of 3 ml/min, followed by perfusion with 
Digestion Buffer for 14 minutes. The ventricles were then removed from the Langendorf 
apparatus and placed in Dissociation Buffer at a temperature of 37°C and gently teased 
apart with forceps. Tissue was then triturated with a transfer pipette, and the cell 
suspension was passed through a 100 μm cell strainer. To begin gradually adding back 
calcium, an equal volume of Dissociation Buffer supplemented with 200 μM Ca2+ was 
then added dropwise to the cell suspension. Cardiomyocytes were enriched by 
centrifugation at 300 RPM for 3 min and resuspended in Dissociation Buffer 
supplemented with 250 μM Ca2+. Cardiomyocytes were then allowed to settle by gravity 
sedimentation for 20 minutes at 37°C and resuspended in 4 mL Dissociation Buffer with 
500 μM Ca2+.  
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Isolation of P7 Cardiomyocytes 
Buffers were prepared on the day of isolation as follows. Cell Isolation Buffer (CIB) was 
the same as used for isolation of adult cardiomyocytes; P7 Digestion Buffer: CIB with 
506 U/mL Collagenase Type II and 0.52 mg/mL Trypsin (Fisher; J63993, 1:250); P7 
Dissociation Buffer: CIB with 506 U/mL Collagenase Type II and 0.52 mg/mL Trypsin, 
10% Horse Serum (Gibco; 16050), 5% Fetal Bovine Serum (Gibco; 10437); P7 Sort 
Buffer: CIB with 0.66% Horse Serum, and 0.33% Fetal Bovine Serum. Hearts were 
removed from 7-day-old mice and placed in ice-cold CIB. YFP+ hearts were identified 
and used for cell isolation.  Under a dissection microscope, atria and extraneous tissue 
were removed, and ventricles were cut into fourths. Each heart was then placed in 2 mL 
P7 Digestion Buffer and incubated for 30 minutes at 37°C with rocking. Each heart was 
then transferred to 2 mL P7 Dissociation Buffer supplemented with 60 μM Ca2+, where it 
was triturated with a transfer pipette followed by a 1000 μL pipette tip. Cell suspensions 
were then combined and passed through a 70 μm cell strainer. The cell suspension was 
then centrifuged twice for 5 minutes at 500 RPM and resuspended first in P7 Dissociation 
Buffer supplemented with 140 μM Ca2+, then in 4 mL P7 Sort Buffer supplemented with 
240 μM Ca2+. VybrantTM DyeCycleTM  Violet was added to the cell suspension at 1 
μL/mL, and cells were incubated at 37°C for 30 minutes prior to FACS.  
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Isolation of E18.5 Cardiomyocytes 
Buffers were prepared on the day of isolation as follows. E18.5 Digestion Buffer: HBSS 
(Gibco; 14170) with 10 mM HEPES (Invitrogen; 15630), 0.54 mM EDTA (Invitrogen; 
15575) and 2 mg/mL Trypsin; E18.5 Dissociation Buffer: HBSS with 10mM HEPES, 
10% Horse Serum, 5% Fetal Bovine Serum; E18.5 Sort Buffer: Opti-MEM (Gibco; 
31985) with 0.66% Horse Serum, and 0.33% Fetal Bovine Serum. Time pregnant females 
were euthanized by CO2 inhalation. Embryos were removed, and hearts were excised and 
placed in ice-cold HBSS. YFP+ hearts were identified and used for cell isolation.  Under 
a dissection microscope, atria and extraneous tissue were removed, and ventricles were 
splayed open. Each heart was then placed in 2 mL E18.5 Digestion Buffer and incubated 
for 10 minutes at 37°C with rocking. Each heart was then transferred in a drop of 
Digestion buffer to a well of a 12 well plate and incubated for 30 minutes. 2 mL E18.5 
Dissociation Buffer was then added to each well, and the heart was triturated with a 1000 
μL pipette tip. Cell suspensions were then combined and passed through a 70 μm cell 
strainer. The cell suspension was then centrifuged for 5 minutes at 500 RPM and 
resuspended in 4 mL E18.5 Sort Buffer. VybrantTM DyeCycleTM  Violet was added to the 
cell suspension at 1 μL/mL, and cells were incubated at 37°C for 30 minutes prior to 
FACS.  
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Sorting Mononucleated and Binucleated Cardiomyocytes by FACS 
VybrantTM DyeCycleTM Violet (Invitrogen; V35003) was added to cell suspensions at 1 
μL/mL and incubated at 37°C for 30 minutes prior to FACS. Cell sorting was performed 
on a MoFlo Astrios EQ (Beckman Coulter) at room temperature. Embryonic and neonatal 
cardiomyocytes were sorted using a 100 um nozzle, while adult cardiomyocytes were 
sorted using a 150 um nozzle with a maximum pressure difference of 1. Cardiomyocytes 
from Mlc2vCre:R26REYFP mice were gated on YFP presence with a 488 nm laser. 
Nucleation was gated on the height and width of the signal from a 405 nm laser as 
described above. Prior to collection, 50-100 cells within each gate were sorted onto a 
slide and imaged with the DAPI, GFP, and transmitted light channels of an EVOS FL 
Auto imaging system microscope (ThermoFisher; AMAFD1000) to ensure correct 
separation of mononucleated and binucleated cells. If necessary, gates were adjusted until 
the targeted cells were correctly identified. For RNA, an equal number of mononucleated 
and binucleated cardiomyocytes were sorted into Trizol-LS (LifeTech; 10296028).  
RNA Isolation for RNA-seq and qPCR 
RNA was isolated by phenol-chloroform extraction followed by precipitation with 75% 
Ethanol. RNA was then purified using the RNeasy micro Kit (Qiagen; 74004) as follows. 
A solution containing precipitated RNA was applied to an RNeasy MinElute Spin 
Column, and washes were done according to the manufacturer's protocol. RNA was then 
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eluted in 20 μL H2O. RNA to be sequenced was tested for integrity via Bioanalyzer using 
the RNA 6000 Pico Kit (Agilent; 5067).  RNA for qPCR was quantified using a 
Nanodrop One (Thermo), and cDNA was generated using the Superscript IV First-Strand 
Synthesis System (ThermoFisher; 18090050). Quantitative Real-Time PCR was 
performed on a QuantStudio 7 Flex with Power SYBR Green PCR Mastermix (Applied 
Biosystems; 4367659). QPCR primer sequences are listed in Table 4.2.    
 
Surgical Procedures  
To induce MI in neonatal mice, we permanently ligated the LAD artery on postnatal day 
1 (P1) as previously described (Leach et al., 2017). To minimize stress and reduce the 
likelihood of the pups being rejected by the nursing dam, only half of the litter was 
removed prior to commencing surgery. Pups were housed in an incubation chamber to 
provide warmth throughout and after the surgical procedure. The dam was housed away 
from the operating table during the procedure. P1 mice were anesthetized by cooling on 
ice. Once the appropriate plane of anesthesia is reached, the neonate was removed from 
the ice for the surgical procedure. Appropriate anesthesia was recognized by a lack of 
breathing, movement, and reflexes. The pup was placed atop a firm operating surface in 
the supine position. Forelimbs and tail were held in position using masking tape. A 
dissecting microscope with a fibro-optic light was used for visualization throughout the 
surgery. A lateral skin incision was then made on the left side of the chest, just below the 
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insertion of the left forelimb, using fine scissors and forceps. Blunt dissection was used to 
expose the ribs, and a lateral thoracotomy was performed at the fourth intercostal space 
by blunt dissection of the intercostal muscles following skin incision. The left anterior 
descending coronary artery (LAD) was identified under the microscope. 8-0 nylon suture 
was then sutured across the LAD and permanently ligated. The visualization of the 
whitish color of the left ventricular apex assured the effective ligation of LAD. Following 
the LAD ligation, the thoracotomy was closed by re-approximating the ribs using a 6-0 
non-absorbable suture. The skin incision was then closed using Vetbond, a skin adhesive 
glue. The entire procedure took less than 10 minutes per mouse. The instruments were 
sterilized between procedures using a hot bead sterilizer. After surgery, pups were 
brought back to body temperature by placing them in a 33C incubator for 20-30 minutes.  
In vitro Experiments 
Cardiomyocytes were isolated from Rbflox/flox;p130flox/flox;p107-/- pups at postnatal day 1. 
Buffers and protocol were as described for isolating E18.5 cardiomyocytes with the 
following modifications. Rinse buffer: DMEM with 10% Horse Serum, 5% Fetal Bovine 
Serum, 1% Pen/Strep. High Serum Culture Media: Opti-MEM with 10% Horse Serum, 
5% Fetal Bovine Serum, 1% Pen/Strep. Low Serum Culture Media:  Opti-MEM with 
0.7% Horse Serum, 0.3% Fetal Bovine Serum, 1% Pen/Strep. Each heart was placed in 2 
mL Digestion Buffer and incubated overnight at 4°C with rocking instead of 10 minutes 
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at 37°C. Following dissociation, cell suspensions were washed with Rinse Media, then 
resuspended in High Serum Culture media and passed through a 70 μm cell strainer. 
Fibroblasts were depleted by plating cell suspensions for 2 hours on cell culture plastic. 
Cell suspensions were then collected, and cells counted with a hemocytometer. 75,000 
cells in High Serum Culture Media were plated in per well of a 48 well plate, precoated 
overnight with 100  g/mL laminin. The following day, each well of cells was treated 
with 5x10^6 PFU of adenovirus expressing either GFP (Ad-GFP) (Vector Biolabs; 1060) 
or both Cre recombinase and GFP (Ad-Cre-GFP) (Vector Biolabs; 1700). The morning 
after adenoviral infection, media was changed to Low Serum Culture Media for 24 hours 
to inhibit the growth of fibroblasts. 36 hours after adenoviral infection, media was 
changed back to High Serum culture media, and cells were cultured for an additional 36 
hours. 72 hours after adenoviral infection, cells were harvested in Trizol for RNA as 
described above or fixed for staining to quantify nucleation. 
 
Histology and Immunostaining 
Single-cell suspensions of cardiomyocytes were fixed in 4% PFA and permeabilized in 
PBS with 0.5% TritonX-100. SEA BLOCK blocking buffer (ThermoFisher; 37527) was 
used for blocking, diluting antibodies, and washes. Cells were incubated with primary 
antibody overnight at 4°C, followed by the secondary antibody for 1 hour at room 
temperature. Cells were then incubated with DAPI, pelleted, resuspended in ProLong 
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Diamond Antifade Mountant (ThermoFisher; P36961), and mounted on slides. Images 
were acquired with the Nikon Eclipse Ni-E microscope, and mononucleated and 
binucleated cells were counted using Fiji Software. Histology was performed by 
members of the Penn Cardiovascular Institute's Histology and Gene Expression Core 
Facility. For Histology, tissues were fixed in 4% paraformaldehyde, dehydrated through a 
series of ethanol washes, and embedded in paraffin. Tissue was sectioned at 6 μm 
intervals and stained with either hematoxylin and eosin, Masson’s trichrome, or by 
immunostaining.  Primary antibody information and concentrations used are listed in 
Table 4.3.  
 
Electron Microscopy 
Cardiomyocytes for electron microscopic examination were sorted directly into fixative 
containing 2.5% glutaraldehyde, 2.0% paraformaldehyde in 0.1M sodium cacodylate 
buffer, pH 7.4, overnight at 4°C. After subsequent buffer washes, the samples were post-
fixed in 2.0% osmium tetroxide for 1 hour at room temperature and rinsed in DH2O prior 
to en bloc staining with 2% uranyl acetate.  After dehydration through a graded ethanol 
series, the tissue was infiltrated and embedded in EMbed-812 (Electron Microscopy 
Sciences, Fort Washington, PA).  Thin sections were stained with uranyl acetate and lead 
citrate and examined with a JEOL 1010 electron microscope fitted with a Hamamatsu 
digital camera and AMT Advantage image capture software. 
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5.3 QUANTIFICATION AND STATISTICAL ANALYSIS 
Statistical Analysis 
Data are reported as Mean ± SEM. Statistical analysis was performed in Prism 7 for Mac. 
Unless otherwise specified, an unpaired Student's t-test was used to compare two 
experimental groups. For injury studies, a Mann-Whitney U test was used.  Data were 
considered significant if p < 0.05. 
 
Quantification of Scar Size  
Scar size was measured as the percent fibrosis of the left ventricle myocardium from the 
site of the suture to the apex using MIQuant, an automated image segmentation open-
source code for MATLAB (Nascimento et al., 2011). The average of two independent 
measurements of scar size is reported. The initial measurement was not obtained blind; to 
ensure reproducibility, a second investigator measured scar size blind to genotype.   
 
RNA-Sequencing and Analysis 
Library prep was conducted using Illumina truSeq stranded mRNA kit and Clontech 
SMARTer RNA-seq amplification kit. Fastq files were assessed for quality control using 
the FastQC program. Fastq files were aligned against the mouse reference genome (mm9) 
using the STAR aligner (Dobin et al., 2013). Duplicate reads were flagged using the 
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MarkDuplicates program from Picard tools. Per gene read counts for Ensembl (v67) gene 
annotations were computed using the R package with duplicate reads removed. Gene 
counts represented as counts per million (CPM) were first nominalized using TMM 
method in the edgeR R package, and genes with 25% of samples with a CPM < 1 were 
removed and deemed low expressed. The data were transformed using the VOOM 
function from the limma R package (Law et al., 2014). Differential gene expression was 
performed as a paired analysis between mono-nuclear and bi-nuclear samples using 
limma. To perform the pair-wise test, the subject correlation was first computed using 
duplicate Correlation() function, and the linear model was then fit using the subject as a 
blocking variable and adjusting for the subject correlation. Given the small sample size of 
the experiment, we employed the empirical Bayes procedure as implemented in limma to 
adjust the linear fit and calculate p-values. p-values were adjusted for multiple 
comparisons using the Benjamini-Hochberg procedure. Heatmaps and PCA plots were 
generated in R. Gene Ontology enrichment analysis was performed using the ToppGene 
Suite (https://toppgene.cchmc.org/) (Chen et al., 2009). 
 
Data and Code Availability  
















Figure 5.1  Generation and genotyping of the floxed Ect2 allele  
A mouse line containing the targeted allele was derived through in-vitro fertilization by 
the Transgenic and Chimeric Mouse Facility at the University of Pennsylvania. 
Genotyping of tails from mice containing the targeted allele with the Kr and Ef primers 
resulted in amplification of a 318 bp PCR product. Once the neomycin cassette is 
removed by breeding to a ROSA26FLPe allele, genotyping of the conditional allele with 
the Ef and Er primers will generate a PCR product of 502 bp whereas the wild type allele 
will generate and PCR product of 402 bp. Figure was adapted from literature provided by 
















Ect2- Kr CCAACAGCTTCCCCACAACGG 
Mlc2vcre Fwd CCAGGGGAGAGGTATTTATTGTTCC 
Mlc2vcre Rev CCAGGTATGCTCAGAAAACGCC 
Nkx2.5cre Fwd CGTTTTCTGAGCATACCTGGA 
Nkx2.5cre Rev ATTCTCCCACCGTCAGTACG 
R26REYFP mut Fwd AAGGGAGCTGCAGTGGAGTA 
R26REYFP mut Rev CCGAAAATCTGTGGGAAGTC 
R26REYFP wt Fwd ACATGGTCCTGCTGGAGTTC 











Table 5.2 qPCR primer sequences 
Gene Sequence 
E2f1 Fwd GGGAGAAGTCACGCTATGAAACCT 
E2f1 Rev ATGTCATAGATGCGCCGTTTCTGC 
Mcm2 Fwd AACTGTAGCAAGTGCAACTTTGT 
Mcm2 Rev GCGGATACGTTGGTAGTTCTGAT 
Ccne2 Fwd ATGTCAAGACGCAGCCGTTTA 
Ccne2 Rev GCTGATTCCTCCAGACAGTACA 
Top2a Fwd CGAGCAAGAAAGCAAAGGG 
Top2a Rev CTTAATTGGCTTCCTCGCC 
Ccne1 Fwd AGCGAGGATAGCAGTCAGCC 
Ccne1 Rev GGTGGTCTGATTTTCCGAGG 
Mcm6 Fwd CCTGTGAATAGGTTCAACGGC 
Mcm6 Rev CATTTTCCTGAGGTGGAGCAC 
Cdt1 Fwd ACAGCCGGGCAAGATCCCCT 
Cdt1 Rev GGCTCCCAACTTCCGTGCCC 
Rfc2 Fwd CTGCCGTGGGTTGAAAAATACA 
Rfc2 Rev CAGAGGATGCTGGTTGTCTTG 
Pcna Fwd TTTGAGGCACGCCTGATCC 
Pcna Rev GGAGACGTGAGACGAGTCCAT 
Cdk5 Fwd CCCTGAGATTGTGAAGTCATTCC 
Cdk5 Rev CCAATTTCAACTCCCCATTCCT 
Myh7 Fwd GAGCCTTGGATTCTCAAACG 
Myh7 Rev GTGGCTCCGAGAAAGGAAG 
Rb1 Fwd TGCATCTTTATCGCAGCAGTT 
Rb1 Rev GTTCACACGTCCGTTCTAATTTG 
Necdin Fwd GGCGCTCAACAACCGTATG 
Necdin Rev CTCGGTGATTATCTTCCTCACG 
Cenpf Fwd GCACAGCACAGTATGACCAGG 
Cenpf Rev CTCTGCGTTCTGTCGGTGAC 
Ect2 Exon13 Fwd TACTCCAGTTCCTCCAAAGCAG 
Ect2 Exon13 Rev GTCCTTCTTCTTCTAAGGGCACC 
Gapdh Fwd TGCACCACCAACTGCTTAGC 
Gapdh Rev GGCATGGACTGTGGTCATGAG 
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Table 5.3 Primary antibodies used for immunostaining 
Antibody Species  Company Catalog # Dilution 
Sarcomeric α-Actinin Mouse Sigma A7811 1:100 
Troponin T-C Goat Santa Cruz sc-8121 1:25 
GFP Goat Abcam ab6673 1:500 
Phospho-Histone H3 Rabbit Cell Signaling 9701 1:150 
Aurora B Kinase Rabbit  Abcam ab2254 1:1000 
Ki67 Rabbit abcam ab16667 1:50 
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